Drug search by name

Dapagliflozin and Metformin Extended-Release Tablets and Bladder cancer

Result of checking the interaction of drug Dapagliflozin and Metformin Extended-Release Tablets and disease Bladder cancer for safety when used together.

Check result:

Dapagliflozin and Metformin Extended-Release Tablets <> Bladder cancer

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

There is insufficient evidence to determine if dapagliflozin has an effect on preexisting bladder tumors or if it can cause bladder cancer. However, the manufacturer does not recommend the use of dapagliflozin in patients with active bladder cancer. In patients with history of bladder cancer the benefit of treatment versus the risk of cancer recurrence during treatment should be considered.

Dapagliflozin and Metformin Extended-Release Tablets

Generic Name: dapagliflozin / metformin

Brand Name: Xigduo XR

Synonyms: Dapagliflozin and metformin, Dapagliflozin and Metformin

What is Dapagliflozin and Metformin Extended-Release Tablets?